Diagnostics

Genetic Technologies Announces Appointment of Chief Financial Officer & Company SecretaryGenetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary

Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary

MELBOURNE, Australia, July 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader…

9 months ago
Teknova Announces Closing of $15.4 Million Private PlacementTeknova Announces Closing of $15.4 Million Private Placement

Teknova Announces Closing of $15.4 Million Private Placement

HOLLISTER, Calif., July 12, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents…

9 months ago
Teknova Announces $15.4 Million Private PlacementTeknova Announces $15.4 Million Private Placement

Teknova Announces $15.4 Million Private Placement

HOLLISTER, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents…

10 months ago
Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024

Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024

SEATTLE, July 11, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to…

10 months ago
Induced Pluripotent Stem Cells Market Size is Expected to Grow at a CAGR of 9.4% and Reach USD 4.6 billion by 2034: Transparency Market Research Inc.Induced Pluripotent Stem Cells Market Size is Expected to Grow at a CAGR of 9.4% and Reach USD 4.6 billion by 2034: Transparency Market Research Inc.

Induced Pluripotent Stem Cells Market Size is Expected to Grow at a CAGR of 9.4% and Reach USD 4.6 billion by 2034: Transparency Market Research Inc.

Induced pluripotent stem cells are experiencing strong growth due to rising research into disease models and drug discovery.  WILMINGTON, Del. ,…

10 months ago
Vendor Neutral Archive (VNA) Market to be Worth USD 1.3 billion by 2034, Growing a CAGR 12.6% – Exclusive Report by Transparency Market Research, Inc.Vendor Neutral Archive (VNA) Market to be Worth USD 1.3 billion by 2034, Growing a CAGR 12.6% – Exclusive Report by Transparency Market Research, Inc.

Vendor Neutral Archive (VNA) Market to be Worth USD 1.3 billion by 2034, Growing a CAGR 12.6% – Exclusive Report by Transparency Market Research, Inc.

The improvement of patient care and compliance is expected to drive demand for a vendor-neutral archive market. A growing concern…

10 months ago
Lucid Diagnostics Launches New Corporate WebsiteLucid Diagnostics Launches New Corporate Website

Lucid Diagnostics Launches New Corporate Website

NEW YORK, July 11, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics…

10 months ago
Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGCSanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC

Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC

SHANGHAI, July 11, 2024 /PRNewswire/ -- Recently, BioGeometry and Sanyou Bio jointly announced the signing of a strategic partnership agreement. BioGeometry…

10 months ago
Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug ScreeningDanaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening

Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening

Predictive tools will seek to reduce leading cause of failure rates in clinical trials of oncology drugs. Integrated AI and…

10 months ago
Element Biosciences Raises Over $277 Million to Develop and Commercialize Differentiated Products and Continue Rapid GrowthElement Biosciences Raises Over $277 Million to Develop and Commercialize Differentiated Products and Continue Rapid Growth

Element Biosciences Raises Over $277 Million to Develop and Commercialize Differentiated Products and Continue Rapid Growth

SAN DIEGO, July 11, 2024 /PRNewswire/ -- Element Biosciences, Inc., developer of pioneering technologies to empower science, today announced over $277…

10 months ago